100, Stuart St

Boston,

MA,

USA,

ZIP: 02116

Phone: +16174554188

Now in 2023 as ESG has transitioned from a value adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your sustainability and business strategy, adhere to brand new global regulations and position your life sciences organization for future success.

Join the most forward thinking ESG, EHS, sustainability, CSR leaders as well as other key stakeholders at the 2nd Annual ESG in Life Sciences Summit and uncover how to operationally embed ESG and sustainability across your biopharma business and tackle industry-specific challenges such as health equity to satisfy future employees, customers, and investors.

This unique and much needed event is your only opportunity to understand how life sciences organizations of all sizes and stages in the US are successfully developing and driving a successful sustainable business strategy now to truly deliver on (science based) targets and commitments.

URLs:
Tickets: https://go.evvnt.com/1923218-2?pid=1052
Brochure: https://go.evvnt.com/1923218-3?pid=1052

Prices:
Life Science Organisations - Conference + Focus Day and Breakfast Deep Dive: USD 3696.00,
Life Science Organisations - Conference + Focus Day: USD 3197.00,
Life Science Organisations - Conference + Breakfast Deep Dive: USD 2698.00,
Life Science Organisations - Conference Only: USD 2199.00,
Standard Pricing - Conference + Focus Day and Breakfast Deep Dive: USD 4696.00,
Standard Pricing - Conference + Focus Day: USD 4097.00,
Standard Pricing - Conference + Breakfast Deep Dive: USD 3498.00,
Standard Pricing - Conference Only: USD 2899.00

Speakers: Alyssa Caddle, Director, Supplier Responsibility, Thermo Fisher Scientific Inc., Angela Bitting, Senior Vice President Corporate Affairs and Chief ESG Officer, Twist Bioscience, Anthony Michetti, Director of Sustainability, Cell Signaling Technology - CST, Arun Skaria, Senior Director Corporate Responsibility and ESG, Alnylam Pharmaceuticals, Casey Stock, Director of ESG and Sustainability, Natera, Chris Shanahan, Vice President Global Sustainability Supply Chain, Thermo Fisher Scientific, Christine Riley Miller, Executive Director - Sustainability and Corporate Social Responsibility, BeiGene, Don Plummer, Chief of Staff, Head of ESG, Arcutis, Donna Finale, Sustainability Lead, UCB S.A., Doug Maffei, Vice President and Head of Investor Relations and ESG, Seagen, Gretchen Govoni, Global Climate Strategy Lead, Takeda Pharmaceutical, Halie Beckert, Senior Manager EHS, Arvinas, Inc., Helen Revelas, Director Environment and Sustainability, Emergent BioSolutions, Itamar Schwartz, Senior Director and Head of Environmental, Social, Governance Reporting and Engagement, Teva Pharmaceuticals, James Connelly, Chief Executive Officer, My Green Lab, Jennifer Wright, Head of Environmental and Sustainability, Pfizer, Jesse Marano, Senior Manager EHS, Emergent BioSolutions, Johanna Jobin, Global Head Corporate Reputation and Responsibility and Executive Director of the Biogen Foundation, Biogen, Klaus Kunz, Vice President and Head of ESG, External Engagement and Performance Reporting, Bayer, Matthew Yamatin, Director Sustainability Program, Thermo Fisher Scientific Inc., Partha Krishnan, Deputy Director HSE, Sanofi, Rachel Taylor, Executive Director ESG Strategy and Engagement, Merck and Co